|
| |
| | | 69523 | | 22.01.2026 | | Eli Lilly (Suisse) SA | | | | | | | 21.01.2031 | | | | | | | | | | 01.99. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Kisunla 350 mg | Konzentrat zur Herstellung einer Infusionslösung | Concentrate for infusion (Donanemabum 350mg / 20ml) | N06DX05 | CI |
|
|
|
